# Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI

> **NCT01355991** · PHASE1 · UNKNOWN · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Spinal Cord Injury

## Interventions

- **DRUG:** Tiotropium
- **DRUG:** Salmeterol

## Key facts

- **NCT ID:** NCT01355991
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2011-08
- **Primary completion:** 2016-03
- **Final completion:** 2016-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2015-10-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01355991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01355991, "Effects of Anticholinergic or Long-Acting Beta 2 Agonist on FeNO and Pulmonary Function in SCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01355991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*